Dynavax Technologies Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Dynavax Technologies Corporation (DVAX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.100.740.620.440.170.150.15
Short-Term Investments0.620.590.420.110.130.000.00
Cash & Short-Term Investments0.710.740.620.550.170.150.15
Accounts Receivable0.050.040.150.120.000.010.00
Inventory0.070.050.060.060.060.040.02
Other Current Assets0.02-0.01-0.010.070.01-0.010.00
Total Current Assets0.850.860.920.970.290.210.17
Non-Current Assets
Property, Plant & Equipment (Net)0.060.060.060.060.060.060.02
Long-Term Investments0.070.000.000.000.000.000.00
Goodwill0.000.000.000.000.000.000.00
Other Non-Current Assets0.000.070.000.000.030.000.01
Total Non-Current Assets0.140.140.070.070.090.070.04
Total Assets0.991.000.991.040.350.280.21
Current Liabilities
Accounts Payable0.010.050.030.000.020.020.03
Short-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities0.030.050.140.180.020.000.00
Deferred Revenue0.000.000.000.350.040.000.00
Other Current Liabilities0.070.010.120.020.010.020.01
Total Current Liabilities0.080.060.150.560.080.050.04
Non-Current Liabilities
Long-Term Debt0.250.250.250.220.210.220.10
Other Non-Current Liabilities0.060.060.000.010.010.010.01
Total Non-Current Liabilities0.310.310.250.260.220.220.11
Total Liabilities0.390.380.400.820.290.270.15
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-0.90-0.93-0.93-1.22-1.29-1.22-1.07
Accumulated Other Comprehensive Income0.000.00-0.010.000.000.000.00
Additional Paid-in Capital1.501.551.511.441.351.231.13
Shares Outstanding0.130.130.130.120.000.000.00
Total Stockholders' Equity0.600.620.580.220.060.010.06
Total Liabilities & Equity0.991.000.991.040.350.280.21